Oct 27, 2020
With our 7th Annual Healthcare Summit less than a month away, we’ve assembled a pre-read packet of the Seven Most Compelling Healthcare Conversations we’ll be facilitating with guests near and far.
Take a few minutes below to get a taste of what’s in store, and be sure to join the conversation (and hear some of the best country music Nashville has to offer) November 10, 11 and 12. I’m confident that our carefully curated Summit experience will strike a chord with your intellectual and musical tastes alike.
1. Reimagining Healthcare
This is such a big topic that we’ve already started the conversation and plan to culminate it vs. kick it off on day one.
“Making Digital Doable” is one of our organizational missions, and while it served as a sort of slogan for our how-to guide for digital transformation, enablement is a perennial topic in healthcare. Continuing our history of making complex topics actionable, we partnered with McKinsey on “Reimagining Healthcare,” a three-part series spun out of the firm’s existing framework for how we, as industry leaders, can achieve reform with an easy-to-follow five step approach.
Catch parts one and two in advance with our short, on-demand webinars. Then, download this series recap, consider it your study guide and have it at the ready as we dig in on November 10.
2. Will COVID-19 Prove a Catalyst for Value-Based Care?
Who better to have this conversation than Brad Smith, deputy administrator and director of The Center for Medicare and Medicaid Innovation (CMMI). In a fireside chat with Cotiviti Chairman, President and CEO Emad Rizk, Smith will discuss the latest payment models making waves, why the COVID-19 coronavirus pandemic is likely to accelerate the move toward value-based care, and what he and CMMI are doing to shift value-based care from “side project” to the core way the country pays for healthcare.
3. Leaning in: How Payers Are Responding to the Pandemic, Systemic Racism and Health Disparities
Issues of epic proportion are forcing payers, providers, policymakers and the populace alike to challenge the status quo, especially when it comes to fair and equal access to health care and coverage. Sen. Bill Frist, M.D., and Florida Blue President and CEO Pat Geraghty get real about the social dilemmas dogging progress and what healthcare payers, providers and technology players can do about it.
4. The Tipping Point of Mainstream Mental Health
The statistics are sobering. Our industry is failing to adequately address mental health. According to the National Alliance on Mental Illness:
- One in five U.S. adults experience mental illness each year
- An average of 11 years passes between the onset of mental illness symptoms and treatment
- Less than 12% of those experiencing mental illness have insurance
- 60% of U.S. counties do not have a practicing psychiatrist
The pandemic brought about a heightened recognition of mental health’s role in our daily lives and overall wellness, and well before this year, the inextricable link between our physical and mental health was studied. Despite widespread acknowledgement of its importance, and an abundance of resources, we’re still struggling as a system and a nation to adequately link mental and physical health and treat the whole person.
This panel will push us to get to the root of how we knock down cost, data and other barriers to approach and treat mental health as more than an afterthought.
5. Dr. AI Has Seen You and Here’s the Issue…
Humans are hardwired to resist change. Will Artificial Intelligence ultimately force our hand?
We’re facing a conundrum when it comes to providing care. Burnt out physicians are operating in a people-focused profession, their job performance increasingly measured by quality and satisfaction. AI is ever-evolving, increasingly able to perform tasks traditionally administered by providers and more widely accepted by patients. Is its use bad bedside manner, countering everything we’ve been taught about the need for high-touch healthcare?
In this session, we’ll weigh the pros and cons of the rise of AI and its integration, and hear first-hand how providers really feel about its ability to lessen their load and improve outcomes.
6. The Public Health (Data) in All of Us
Crises reveal weaknesses, and in several ways, COVID-19 brought healthcare to its knees.
While the pandemic spotlighted our industry’s strengths, it also highlighted our shortcomings, including lack of interoperability and longstanding data silos. Today, we’re proceeding with much trepidation into the thick of what CDC Director Robert Redfield warned could be “the worst fall, from a public health perspective, we’ve ever had,” and bracing for future catastrophes equipped with learnings gained this year.
In preparing for the future, we must assess the present. Discussion will be centered on the systems, processes and tools fundamental to healthcare’s operation, and what can be done now to mitigate potential disruption.
7. Interoperability Is Coming, but Is It All That We Need?
Are we willing to relinquish highly personal information if doing so means keeping ourselves or our loved ones alive?
Patients’ fight for access to their health data is a tale as old as time. Unfortunately, it took a catastrophic global incident to expedite the realization of their demand. Knowing information is only as good as what we do with it, there’s much speculation about where, collectively, we go from here.
Will patients be empowered by this new level of access? Will they use it to help make meaningful changes in how we use data to make care decisions? What potential problems associated with this new era of interoperability could arise? We’ll answer these questions and others in what’s sure to be an impassioned discourse.
OK, I know I said seven compelling conversations, but the deal flow this year is just so interesting that we had to add this bonus session — The New Deal: Innovation Investing — about the changes in healthcare investing spurred by the pandemic, where investors are putting their money (2020 is the largest funding year in history for digital health), and predictions for the future. Has your organization seen a piece of the funding pie? Whether your answer is yes or no, you won’t want to miss our deep dive on this one, led by Blue Venture Fund Managing Director Anna Haghgooie.
Compelling? We’ve just scratched the surface. If you haven’t already, request an invitation and join the conversation during this very special virtual event broadcasting live from Nashville November 10-12. We look forward to seeing you. In the meantime, be the first to be informed of Summit-related news by subscribing to our updates and following us on LinkedIn, Twitter and Facebook.
As the Chief Strategy and Growth Officer, Balajee Sethuraman drives the firm’s go to market strategy and growth initiatives, while driving multiple transformation threads to further consolidate Emids’ position as a digital transformation leader in Healthcare. Balajee brings over 23 years in driving strategic growth in entrepreneurial high growth settings across the United States and Europe. Balajee is a seasoned technology leader with strong commercial, operations and technology experience, helping scale businesses and pivot business to enable digital transformation. Balajee’s background cuts across Services, Products and Platforms. Connect with Balajee on LinkedIn.